To study whether addition of human LH hormone (Luveris) during the final days of stimulation
with recombinant FSH (Gonal-f) for controlled ovarian stimulation will be of benefit for
patients undergoing in vitro fertilisation.
Phase:
Phase 4
Details
Lead Sponsor:
Rigshospitalet, Denmark
Collaborators:
Helse Fonna Herlev Hospital Holbaek Sygehus Hvidovre University Hospital Karolinska University Hospital Odense University Hospital Regionshospitalet Viborg, Skive Turku Hospital